1 / 29

“ Was blind but now I see…”

“ Was blind but now I see…”. Grand Ward Round Dr Heng Li Wei 5 th June 2008. History. 74 / Indian / F DM on OHGA, hypt (diet control) Sudden onset of LE visual loss on waking up x 1 day - Painless, no eye redness, no other neurological symptoms. Examination.

dorie
Télécharger la présentation

“ Was blind but now I see…”

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. “ Was blind but now I see…” Grand Ward Round Dr Heng Li Wei 5th June 2008

  2. History • 74 / Indian / F • DM on OHGA, hypt (diet control) • Sudden onset of LE visual loss on waking up x 1 day - Painless, no eye redness, no other neurological symptoms.

  3. Examination • VR - 6/7.5 VL - CF 3ft pH -> 6/60 • No RAPD. • Anterior segment: - Mild cataracts. Otherwise NAD • IOP 19mmHg BE.

  4. Examination • Confrontational VF LE RE HM HM HM CF CF HM CF CF HM HM

  5. Posterior segment: • RE - NAD. No DR. • LE • Disc pink, no disc edema, CDR 0.3 • Slight pallor & edema over macula • Rest of retina pink.

  6. D/dx sudden painless LOV • “ Vascular” – CRAO, CRVO • “ Neuro” – AION ( arteritic / non-arteritic) • “ Retina” - RD - Vitreous h’age ( PDR, NV, retina tear) - Wet ARMD with breakthrough h’age

  7. OCT OD OS 219 microns 189 microns

  8. FFA 43s 1.5min 4min 8min

  9. Mgmt • Treat as for Left CRAO • Mgmt? - acute - subsequent workup

  10. Ocular massage • Carbogen therapy • Timolol LE – stat & bd • T aspirin 100mg om & famotidine 20mg bd • Pt refused AC tap • Pt declined adm for CVM & Neuro r/v.

  11. The next day… • Pt was very happy, said VA improved overnight. • VR 6/9 VL 6/12 • Left RAPD grade 1 • VF by confrontation – left paracentral nasal field blurring. • Ishihara - R: 15/15 L: 9/15 • Red desaturation - R: 100% L: 40% • Posterior segment – ISQ.

  12. R/v 2 weeks later • VR 6/7.5 VL 6/9 • Left RAPD grade 1 • Ishihara - R: 15/15 L: 3/15 • LE – very mild retina edema over macula. • U/S carotids – 28/5/08 • Neuro TCU – 13/6/08 • CVM / 2DE TCU – 13/6/08 • Referred to OPD to control DM & hypt. • TCU Neuro-Oph 2 months.

  13. CRAO protocol

  14. CRAO • Causes • Fundus appearance • Prognosis / visual outcome • Treatment

  15. CRAO - CAUSES

  16. Susac syndrome 1 • Triad of retinal artery occlusion, sensorineural deafness, encephalopathy • Rare • Microangiopathy affecting pre-capillary arterioles of brain, retina & inner ear. • Young women in young adulthood. • Pathogenesis – unknown. • Clinical course – recurrent attacks, spont resolution but may have sensory & neurologic sequelae. • Rx: steriods, immunosuppressants, immunoglobulin.

  17. Orbital infarction syndrome 2 • Rare • P/w: acute blindness, orbital pain, total ophthalmoplegia, ant & post segment ischaemia. • Proposed mechanisms: • Acute perfusion failure eg. CCA occlusion • Systemic vasculitis eg GCA • Orbital cellulitis with vasculitis

  18. Fundus changes in CRAO 3 • 248 eyes: permanent CRAO (175), w cilioretinal artery sparing (35), transient CRAO (38). • Initial findings in permanent CRAO: - Cherry red spot (90%) - Retinal opacity in posterior pole (58%) - Arterial attenuation, disc edema & pallor, box-carring. • Later stage findings: - Optic atrophy, arterial attentuation, cilioretinal collaterals, macular RPE changes. • 4% of CRAO had simultaneous bilateral onset. • Intraarterial emboli observed in 20% of pts.

  19. Prognosis / Visual Outcome 4 • Poor except those with cilioretinal artery-sparing. • 15-20% of general population have cilioretinal artery. • 25% of CRAO have cilioretinal artery. • VA improvement primarily w/n first 7 days. • VA improvement: - transient NA-CRAO (82%), NA-CRAO w cilioret artery sparing (67%), NA-CRAO (22%).

  20. Treatment • Medical therapy + ocular massage + carbogen therapy + AC paracentesis. • Intra-arterial thrombolysis (IAT) • Hyperbaric O2 therapy (HBO) • Transluminal Nd:Yag embolysis/embolectomy (TYL/E) • Transcorneal electrical stimulation

  21. Intra-arterial thrombolysis (IAT) 5 • Systemic rv on literature on IAT • 23 studies, 8 selected for analysis. • 158 pts. • Rx instituted w/n average of 8.4h from onset of symptoms. • VA improvement in 93% pts -> 13% (>20/20), 25% (>20/40), 41% (>20/200). • Complication rate – 4.5%.

  22. Hyperbaric Oxygenation Therapy(HBO) 6 • Off-label use • W/n 12 hr of onset of symptoms • Early Rx (<2h) may be associated with increased visual recovery • Other uses: - retinal vein occlusion with CMO - scleral necrosis after pterygium Sx - orbital rhino-cerebral mucormycosis - anterior segment ischaemia.

  23. Transluminal Nd:Yag embolysis / embolectomy 7 • Photodisrupt emboli w/n CRA/BRA to achieve rapid retinal reperfusion • Embolysis – embolus fragmented w/n lumen • Embolectomy – embolus observed to pass into vitreous • Cx: vitreous h’age, subhyaloid h’age

  24. Transcorneal electrical stimulation (TES) 8 • Longstanding CRAO/BRAO • Jap studies • Bipolar contact lens electrode, once 1 mth x 3 mths. • Outcome measures - perimetric and/or electrophysiological exam • VA improved by >0.2 logMar units in 2/3 cases. • Visual fields improved in all 3 cases. • Multifocal ERG improved in 2/3 cases.

  25. References • Saliba et al. Susac syndrome and ocular manifestation in a 14-year-old girl. J Fr Ophtalmol. 2007 Dec;30(10):1017-22. • Borruat et al. Orbital infarction syndrome. Ophthalmology. 1993 Apr;100(4):562-8. • Havreb et al. Fundus changes in central retinal artery occlusion. Retina. 2007 Mar;27(3):276-89. • Hayreh et al. Central retinal artery occlusion: visual outcome. Am J Ophthalmol. 2005 Sep;140(3):376-91. • Noble J et al. Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review. Br J Ophthalmol. 2008 May;92(5):588-93. • Oguz H et al. The use of hyperbaric oxygen therapy in ophthalmology. Surv Ophthalmol. 2008 Mar-Apr;53(2):112-20. • Opremcak et al. Restoration of retinal blood flow via translumenal Nd:YAG embolysis/embolectomy (TYL/E) for central and branch retinal artery occlusion. Retina. 2008 Feb;28(2):226-35. • Inomata K et al. Transcorneal electrical stimulation of retina to treat longstanding retinal artery occlusion. Graefes Arch Clin Exp Ophthalmol. 2007 Dec;245(12):1773-80. Epub 2007 Jun 26.

More Related